Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

Abstract The increased incidence of secondary hematologic malignancies (SHM) is a well-known, potentially fatal, complication after cancer treatment. It is unknown if patients with ductal carcinoma in situ (DCIS) of the breast treated with external beam radiotherapy (RT) and who survive long-term ha...

Full description

Bibliographic Details
Main Authors: Kang Wang, Zhuyue Li, Xingxing Chen, Jianjun Zhang, Yongfu Xiong, Guochao Zhong, Yang Shi, Qing Li, Xiang Zhang, Hongyuan Li, Tingxiu Xiang, Theodoros Foukakis, Tomas Radivoyevitch, Guosheng Ren
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-021-00228-6

Internet

https://doi.org/10.1038/s41523-021-00228-6

Similar Items